These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12812824)

  • 21. Current thyroid cancer trends in the United States.
    Davies L; Welch HG
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):317-22. PubMed ID: 24557566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic and intra-racial disparities in early-onset colorectal cancer in the SEER 18 registries of the United States.
    Abualkhair WH; Zhou M; Ochoa CO; Lacayo L; Murphy C; Wu XC; Karlitz JJ
    Cancer Med; 2020 Dec; 9(23):9150-9159. PubMed ID: 33094553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambient ultraviolet radiation exposure and hepatocellular carcinoma incidence in the United States.
    VoPham T; Bertrand KA; Yuan JM; Tamimi RM; Hart JE; Laden F
    Environ Health; 2017 Aug; 16(1):89. PubMed ID: 28821245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
    Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
    Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
    Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD
    Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
    Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
    Altekruse SF; McGlynn KA; Reichman ME
    J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI; Anderson BO; Daling JR; Moe RE
    JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambient PM
    VoPham T; Bertrand KA; Tamimi RM; Laden F; Hart JE
    Cancer Causes Control; 2018 Jun; 29(6):563-572. PubMed ID: 29696510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.
    Ramirez AG; Weiss NS; Holden AE; Suarez L; Cooper SP; Munoz E; Naylor SL
    PLoS One; 2012; 7(4):e35573. PubMed ID: 22530052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
    Davila JA; El-Serag HB
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):104-10; quiz 4-5. PubMed ID: 16431312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.
    Ahmed F; Perz JF; Kwong S; Jamison PM; Friedman C; Bell BP
    Prev Chronic Dis; 2008 Jul; 5(3):A74. PubMed ID: 18558024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.
    El-Serag HB; Sardell R; Thrift AP; Kanwal F; Miller P
    Dig Dis Sci; 2021 Mar; 66(3):912-916. PubMed ID: 32303951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.
    Franco RA; Fan Y; Jarosek S; Bae S; Galbraith J
    Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S40-S48. PubMed ID: 30670200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.
    Henley SJ; Anderson RN; Thomas CC; Massetti GM; Peaker B; Richardson LC
    MMWR Surveill Summ; 2017 Jul; 66(14):1-13. PubMed ID: 28683054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
    Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
    PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.
    Ford MM; Ivanina E; Desai P; Highfield L; Qiao B; Schymura MJ; Laraque F
    Cancer Causes Control; 2017 Jul; 28(7):779-789. PubMed ID: 28573469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.